EICHORCondition: Liver Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of the study is to find out the effects of using nivolumab with Drug Eluting Bead Transarterial Chemoembolization (deb-TACE) in the treatment of liver cancer.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Washington University School of Medicine | St Louis, Missouri, United States | — |
| Memorial Sloan Kettering at Basking Ridge | Basking Ridge, New Jersey, United States | — |
| Memorial Sloan Kettering Monmouth | Middletown, New Jersey, United States | — |
| Memorial Sloan Kettering Bergen | Montvale, New Jersey, United States | — |
| Memorial Sloan Kettering Cancer Commack | Commack, New York, United States | — |
| Memorial Sloan Kettering Westchester | Harrison, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Memorial Sloan Kettering Nassau | Uniondale, New York, United States | — |
| Abramson Cancer Center at University of Pennsylvania Medical Center | Philadelphia, Pennsylvania, United States | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03143270